|
Topchoice Medical Corporation (600763.SS) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Topchoice Medical Corporation (600763.SS) Bundle
Looking to assess the intrinsic value of Topchoice Medical Corporation? Our (600763SS) DCF Calculator integrates real-world data with comprehensive customization features, enabling you to adjust forecasts and enhance your investment strategies.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,087.9 | 2,780.7 | 2,718.6 | 2,846.5 | 2,873.8 | 3,136.8 | 3,424.0 | 3,737.4 | 4,079.5 | 4,452.9 |
| Revenue Growth, % | 0 | 33.19 | -2.23 | 4.7 | 0.95798 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 |
| EBITDA | 783.1 | 1,157.3 | 961.3 | 953.2 | 942.9 | 1,134.2 | 1,238.0 | 1,351.3 | 1,475.0 | 1,610.0 |
| EBITDA, % | 37.51 | 41.62 | 35.36 | 33.49 | 32.81 | 36.16 | 36.16 | 36.16 | 36.16 | 36.16 |
| Depreciation | 92.9 | 71.4 | 173.3 | 244.6 | 203.4 | 182.3 | 199.0 | 217.2 | 237.1 | 258.8 |
| Depreciation, % | 4.45 | 2.57 | 6.37 | 8.59 | 7.08 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 |
| EBIT | 690.3 | 1,085.9 | 788.0 | 708.6 | 739.4 | 951.8 | 1,039.0 | 1,134.1 | 1,237.9 | 1,351.2 |
| EBIT, % | 33.06 | 39.05 | 28.99 | 24.89 | 25.73 | 30.34 | 30.34 | 30.34 | 30.34 | 30.34 |
| Total Cash | 674.1 | 844.0 | 630.3 | 594.5 | 622.0 | 805.2 | 878.9 | 959.4 | 1,047.2 | 1,143.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 66.5 | 73.5 | 105.0 | 201.9 | 225.9 | 154.6 | 168.7 | 184.2 | 201.0 | 219.5 |
| Account Receivables, % | 3.18 | 2.64 | 3.86 | 7.09 | 7.86 | 4.93 | 4.93 | 4.93 | 4.93 | 4.93 |
| Inventories | 17.7 | 20.3 | 22.9 | 24.8 | 30.0 | 27.2 | 29.7 | 32.4 | 35.4 | 38.6 |
| Inventories, % | 0.84588 | 0.73157 | 0.8422 | 0.87127 | 1.04 | 0.86689 | 0.86689 | 0.86689 | 0.86689 | 0.86689 |
| Accounts Payable | 167.8 | 173.5 | 140.5 | 183.3 | 136.7 | 192.2 | 209.8 | 229.0 | 250.0 | 272.9 |
| Accounts Payable, % | 8.04 | 6.24 | 5.17 | 6.44 | 4.76 | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 |
| Capital Expenditure | -170.5 | -367.3 | -421.5 | -508.9 | -332.1 | -416.0 | -454.1 | -495.7 | -541.1 | -590.6 |
| Capital Expenditure, % | -8.17 | -13.21 | -15.51 | -17.88 | -11.56 | -13.26 | -13.26 | -13.26 | -13.26 | -13.26 |
| Tax Rate, % | 27.75 | 27.75 | 27.75 | 27.75 | 27.75 | 27.75 | 27.75 | 27.75 | 27.75 | 27.75 |
| EBITAT | 500.0 | 783.1 | 585.4 | 500.3 | 534.3 | 688.6 | 751.6 | 820.4 | 895.5 | 977.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 506.0 | 483.2 | 270.2 | 179.9 | 329.7 | 584.5 | 497.4 | 543.0 | 592.7 | 646.9 |
| WACC, % | 7.18 | 7.18 | 7.18 | 7.17 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 2,326.0 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 666 | |||||||||
| Terminal Value | 15,950 | |||||||||
| Present Terminal Value | 11,278 | |||||||||
| Enterprise Value | 13,604 | |||||||||
| Net Debt | 694 | |||||||||
| Equity Value | 12,910 | |||||||||
| Diluted Shares Outstanding, MM | 448 | |||||||||
| Equity Value Per Share | 28.84 |
Benefits of Choosing Us
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator, featuring pre-filled financial data for Topchoice Medical Corporation (600763SS).
- Accurate Data: Access to historical performance and forward-looking estimates (highlighted in the yellow cells).
- Flexible Forecasting: Adjust assumptions related to revenue growth, EBITDA %, and WACC as needed.
- Instant Calculations: Quickly observe how your inputs influence the valuation of Topchoice Medical Corporation (600763SS).
- Professional-Grade Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Interface: Organized for straightforward navigation, complete with step-by-step guidance.
Key Features
- Real-Time Data on Topchoice Medical: Pre-populated with the historical financial performance and future projections of Topchoice Medical Corporation.
- Customizable Parameters: Tailor revenue growth, profit margins, weighted average cost of capital (WACC), tax rates, and capital expenditures to suit your analysis.
- Interactive Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive User Interface: Designed for both seasoned professionals and newcomers, featuring a clear and organized layout.
How It Operates
- Download: Obtain the pre-configured Excel file containing Topchoice Medical Corporation's (600763SS) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
- Update Automatically: Enjoy real-time updates for intrinsic value and NPV calculations.
- Test Scenarios: Generate various projections and compare results instantly.
- Make Decisions: Leverage the valuation insights to inform your investment strategies.
Why Opt for This Calculator?
- Precision: Leveraged financial data from Topchoice Medical Corporation ensures high accuracy.
- Versatility: Built to allow users to easily modify and experiment with various inputs.
- Efficiency: Eliminate the need to construct a DCF model from the ground up.
- High-Quality: Crafted with the standards and usability expected at the CFO level.
- Accessible: Intuitive interface designed for users at all levels of financial expertise.
Who Can Benefit from This Product?
- Investors: Assess Topchoice Medical Corporation's (600763SS) valuation prior to making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and validate financial projections.
- Startup Founders: Gain insights into how significant public companies like Topchoice Medical Corporation (600763SS) are evaluated.
- Consultants: Create comprehensive valuation reports for your clients.
- Students and Educators: Incorporate real-time data to learn and instruct on valuation practices.
Contents of the Template
- Preloaded TCMC Data: Historical and forecasted financial metrics, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Advanced sheets for determining intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Cells highlighted in yellow for customizing revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financial reports for in-depth analysis.
- Key Ratios: Ratios for profitability, leverage, and efficiency to assess performance.
- Dashboard and Charts: Visual representations of valuation results and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.